Efficacy and Safety of Apixaban versus Dalteparin as a Treatment for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis

Background and Objectives: Venous thromboembolism (VTE) is common in cancer patients. Anticoagulant therapy with low-molecular-weight heparins (LMWHs) and direct oral anticoagulants (DOACs), such as dalteparin and apixaban, have demonstrated efficacy and safety. However, more comparative research of...

Descripción completa

Detalles Bibliográficos
Autores principales: Arce-Huamani, Miguel A., Barboza, Joshuan J., Martínez-Herrera, José Fabián, Torres-Roman, J. Smith, Maguiña, Jorge L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607997/
https://www.ncbi.nlm.nih.gov/pubmed/37893585
http://dx.doi.org/10.3390/medicina59101867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607997/
https://www.ncbi.nlm.nih.gov/pubmed/37893585
http://dx.doi.org/10.3390/medicina59101867

Ejemplares similares